TAM
VRNA

Tucker Asset Management’s Verona Pharma VRNA Stock Holding History

Tucker Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-372
Closed -$7.86K – 1565
2023
Q2 		$7.86K Sell
372
-2,074
-85% -$44.2K ﹤0.01% 587
2023
Q1 		$49.1K Buy
+2,446
New +$52.8K 0.01% 251

Other funds holding VRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Tucker Asset Management's VRNA Position: Q3 2023 in Review

Tucker Asset Management sold out of Verona Pharma (VRNA) in Q3 2023, closing a stake of 372 shares — an estimated $7.86K sold.

Tucker Asset Management first reported a position in VRNA in Q1 2023 and held it in 2 quarters. The position peaked at $49.1K in Q1 2023. 102 funds tracked by Wall St. Rank hold VRNA as of Q3 2023.

  • Tucker Asset Management reported no remaining Verona Pharma position as of Q3 2023 after selling out during the quarter.
  • Tucker Asset Management sold 372 Verona Pharma shares in Q3 2023, an estimated $7.86K.
  • Tucker Asset Management first reported a position in Verona Pharma in Q1 2023 and held it in 2 quarters.
  • Tucker Asset Management's Verona Pharma position peaked at $49.1K in Q1 2023.
  • 102 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2023.

Based on Tucker Asset Management's 13F filing for Q3 2023, filed 4 Dec 2023.